Current limitations and ongoing initiatives to evaluate the activity, damage and outcome of primary Sj ögren's syndrome.

Current limitations and ongoing initiatives to evaluate the activity, damage and outcome of primary Sjögren's syndrome. Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):24-26 Authors: De Vita S, Zabotti A, Gandolfo S PMID: 31464671 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31464671?dopt=Abstract

Source: Clinical and Experimental Rheumatology - August 31, 2019 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research

More News: Rheumatology